Silene Barbieri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Silene Barbieri has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Etges
Universidade Federal de Pelotas
1 shared publication - Ana Carolina Uchoa Vasconcelos
Professor, Department of Operative Dentistry, Faculty of Pharmacy, Dentistry and Nursing; Postgraduate Program in Dentistry, Federal University of Ceará - UFC, Fortaleza, Ceará, Brazil
1 shared publication - Ana Paula Neutzling Gomes
Universidade Federal de Pelotas, Brazil
1 shared publication - Andreia Morales Cascaes
Federal University of Santa Catarina (UFSC), Florianópolis, Brazil
1 shared publication - Lauren Frenzel Schuch
Department of Diagnosis in Pathology and Oral Medicine, School of Dentistry Universidad de la República Montevideo Uruguay
1 shared publication - Ricardo Alves Mesquita
Department of Oral Surgery, Pathology and Clinical Dentistry School of Dentistry, Universidade Federal de Minas Gerais Belo Horizonte Minas Gerais Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Brazilian Oral Research
- Vol. 36, e044
Does smoking habit affect dendritic cell expression in oral squamous cell carcinoma?
The aim of this study was to determine the presence of immature CD1a+ and mature CD83+ dendritic cells in oral squamous cell carcinoma, to compare immunoreactivity between smokers and nonsmokers, and to correlate the results with histopathological grading. In this observational study, twenty-eight paraffin-embedded biopsies of oral squamous cell carcinoma were retrospectively retrieved and submitted to immunohistochemistry for immature CD1a+ and mature CD83+. Descriptive and statistical analyses were performed. The sample consisted of 18 man (64.3%) and 10 women (35.7%), with a mean age of 64.6 years in the nonsmoker group and 53.2 years in the smoker group. The tongue (11 cases, 39.2%) was the most commonly affected anatomical site, followed by gingiva (6 cases, 21.4%). Histopathological grading revealed 7 low-grade and 7 high-grade malignancy cases in each group, and no correlation with the number of positive DCs. The number of immature CD1a+ was not significantly different between smoker and nonsmoker groups, while a lower number of mature CD83+ was detected in the smoker group (p = 0.001). Smoking changes the oral immune system and decreases the ability to activate and mature dendritic cells, which may influence the development and progression of oral squamous cell carcinoma.
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Brazilian Oral Research
- Vol. 36, e044
Open AccessDoes smoking habit affect dendritic cell expression in oral squamous cell carcinoma?
The aim of this study was to determine the presence of immature CD1a+ and mature CD83+ dendritic cells in oral squamous cell carcinoma, to compare immunoreactivity between smokers and nonsmokers, and to correlate the results with histopathological grading. In this observational study, twenty-eight paraffin-embedded biopsies of oral squamous cell carcinoma were retrospectively retrieved and submitted to immunohistochemistry for immature CD1a+ and mature CD83+. Descriptive and statistical analyses were performed. The sample consisted of 18 man (64.3%) and 10 women (35.7%), with a mean age of 64.6 years in the nonsmoker group and 53.2 years in the smoker group. The tongue (11 cases, 39.2%) was the most commonly affected anatomical site, followed by gingiva (6 cases, 21.4%). Histopathological grading revealed 7 low-grade and 7 high-grade malignancy cases in each group, and no correlation with the number of positive DCs. The number of immature CD1a+ was not significantly different between smoker and nonsmoker groups, while a lower number of mature CD83+ was detected in the smoker group (p = 0.001). Smoking changes the oral immune system and decreases the ability to activate and mature dendritic cells, which may influence the development and progression of oral squamous cell carcinoma.